Different Marketing Claims Wegovy was aggressively marketed directly to consumers for weight loss Ozempic marketing technically focused on diabetes but implied weight benefits Social media influencers promoted both (often Ozempic off-label) Marketing materials affect what representations were made to you Example Case Scenarios Scenario A: Type 2 Diabetic on Ozempic Patient: 58-year-old with 10-year diabetes history Prescription: Ozempic 1.0 mg weekly for A1C control Result: Developed severe gastroparesis requiring feeding tube Legal claim: Even for approved use, warnings about gastroparesis were inadequate Scenario B: Weight Loss Patient on Ozempic (Off-Label) Patient: 42-year-old seeking to lose 40 pounds, no diabetes Prescription: Ozempic 2.0 mg (prescribed off-label by weight loss clinic) Result: Chronic vomiting, diagnosed with gastroparesis Legal claim: Off-label promotion and inadequate warnings for weight-loss use Scenario C: Obesity Patient on Wegovy Patient: 35-year-old with BMI 38, prescribed for weight management Prescription: Wegovy escalated to 2.4 mg Result: Intestinal blockage requiring emergency surgery Legal claim: Despite approved use, risks were not adequately disclosed All three scenarios may have valid legal claims , but the specific arguments and evidence will differ

As exendin-4 is more resistant to DPP-4-induced degradation, this mechanism is not activated by exendin-4.241 GLP-1(936) can directly act on pancreatic -cells to inhibit the secretion of glucagon
Some people consider glutathione to get antioxidant support and detoxing capabilities
For nausea, antihistamine antiemetics such as cyclizine or promethazine are available from pharmacies (not general sale) and may be appropriate for short-term use, though they can cause drowsiness
PMID 10369661
Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries